Advertisement

Breast Cancer Research and Treatment

, Volume 138, Issue 2, pp 633–641 | Cite as

A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase

  • Ningqi Hou
  • Dezheng Huo
Brief Report

Abstract

Recent reports have shown that the breast cancer incidence rate in the US stabilized after a sharp reduction in 2002 and 2003. It is important to continue monitoring breast cancer incidence rates according to age group, race/ethnicity, estrogen receptor (ER) status, and tumor stage. Age-standardized breast cancer incidence rates were calculated using data from the surveillance, epidemiology, and end results 18 registries from 2000 to 2009, for 677,774 female breast cancer patients aged 20 and above. Jointpoint regression models were used to fit a series of joined straight lines on a log scale to annual age-standardized rates. The incidence rates of all breast cancer significantly increased for non-Hispanic blacks from 2005 to 2009 (annual percentage change, APC = 2.0 %, p = 0.01) and Asian/Pacific Islanders from 2000 to 2009 (APC = 1.2 %, p = 0.02). Since 2004, incidence rates in women aged 40–49 years significantly increased for most racial/ethnic groups (overall APC = 1.1 %, p = 0.001). The incidence rate of carcinoma in situ significantly increased in all racial/ethnic groups, with an APC range from 2.3 to 3.0 % (p < 0.005). The localized breast cancer incidence significantly increased in non-Hispanic blacks (APC = 1.3 %, p = 0.004) and Asians (APC = 1.2 %, p = 0.03). ER-positive breast cancer significantly increased in almost all age/race sub-groups after 2005 (APC by race: non-Hispanic whites 1.5 %, non-Hispanic blacks 4.3 %, Asian/Pacific Islanders 1.7 %, and Hispanics 1.8 %; all p values <0.05), while ER-negative breast cancer decreased in most sub-groups (APC by race: non-Hispanic whites—3.9 %, non-Hispanic blacks—3.7 %, Asian/Pacific Islanders—1.5 %, and Hispanics—4.3 %; all p values <0.05). Recently the incidence of breast cancer appears to be increasing in certain subgroups, including ER-positive, early-stage breast cancers, in particular among non-Hispanic blacks and Asian/Pacific Islanders. Further studies are warranted to examine possible reasons for these changes, such as changes in mammography screening methods and risk factors prevalence.

Keywords

Breast cancer Incidence SEER Race Hormone receptors Subgroup 

Notes

Acknowledgments

The authors thank Walmy E. Sveen for her critical reading of the manuscript.

Conflict of interest

There are no potential conflicts of interest.

References

  1. 1.
    Jemal A, Ward E, Thun MJ (2007) Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res 9(3):R28. doi: 10.1186/bcr1672 CrossRefPubMedGoogle Scholar
  2. 2.
    Katalinic A, Rawal R (2008) Decline in breast cancer incidence after decrease in utilisation of hormone replacement therapy. Breast Cancer Res Treat 107(3):427–430. doi: 10.1007/s10549-007-9566-z CrossRefPubMedGoogle Scholar
  3. 3.
    Ravdin PM, Cronin KA, Howlader N, Berg CD, Chlebowski RT, Feuer EJ, Edwards BK, Berry DA (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356(16):1670–1674. doi: 10.1056/NEJMsr070105 CrossRefPubMedGoogle Scholar
  4. 4.
    Chlebowski RT, Hendrix SL, Langer RD, Stefanick ML, Gass M, Lane D, Rodabough RJ, Gilligan MA, Cyr MG, Thomson CA, Khandekar J, Petrovitch H, McTiernan A (2003) Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women: the Women’s Health Initiative Randomized Trial. JAMA 289(24):3243–3253. doi: 10.1001/jama.289.24.3243 CrossRefPubMedGoogle Scholar
  5. 5.
    Cronin KA, Ravdin PM, Edwards BK (2009) Sustained lower rates of breast cancer in the United States. Breast Cancer Res Treat 117(1):223–224. doi: 10.1007/s10549-008-0226-8 CrossRefPubMedGoogle Scholar
  6. 6.
    Krieger N, Chen JT, Waterman PD (2010) Decline in US breast cancer rates after the Women’s Health Initiative: socioeconomic and racial/ethnic differentials. Am J Public Health 100(Suppl 1):S132–S139. doi: 10.2105/AJPH.2009.181628 CrossRefPubMedGoogle Scholar
  7. 7.
    DeSantis C, Howlader N, Cronin KA, Jemal A (2011) Breast cancer incidence rates in US women are no longer declining. Cancer Epidemiol Biomarkers Prev 20(5):733–739. doi: 10.1158/1055-9965.EPI-11-0061 CrossRefPubMedGoogle Scholar
  8. 8.
    Eheman C, Henley SJ, Ballard-Barbash R, Jacobs EJ, Schymura MJ, Noone AM, Pan L, Anderson RN, Fulton JE, Kohler BA, Jemal A, Ward E, Plescia M, Ries LA, Edwards BK (2012) Annual Report to the Nation on the status of cancer, 1975–2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 118(9):2338–2366. doi: 10.1002/cncr.27514 CrossRefPubMedGoogle Scholar
  9. 9.
    Anderson WF, Katki HA, Rosenberg PS (2011) Incidence of breast cancer in the United States: current and future trends. J Natl Cancer Inst 103(18):1397–1402. doi: 10.1093/jnci/djr257 CrossRefPubMedGoogle Scholar
  10. 10.
    SEER-18 Surveillance, Epidemiology, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence—SEER 18 Regs Research Data, Nov 2011 Sub (1973–2009) < Katrina/Rita Population Adjustment >—Linked To County Attributes—Total U.S., 1969–2010 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Surveillance Systems Branch, released Apr 2012, based on the Nov 2011 submission
  11. 11.
    White IR, Royston P (2009) Imputing missing covariate values for the Cox model. Stat Med 28(15):1982–1998. doi: 10.1002/sim.3618 CrossRefPubMedGoogle Scholar
  12. 12.
    Van Buuren S, Boshuizen HC, Knook DL (1999) Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 18(6):681–694CrossRefPubMedGoogle Scholar
  13. 13.
    Kim HJ, Fay MP, Feuer EJ, Midthune DN (2000) Permutation tests for joinpoint regression with applications to cancer rates. Stat Med 19(3):335–351CrossRefPubMedGoogle Scholar
  14. 14.
    Pfeiffer RM, Mitani A, Matsuno RK, Anderson WF (2008) Racial differences in breast cancer trends in the United States (2000–2004). J Natl Cancer Inst 100(10):751–752. doi: 10.1093/jnci/djn112 CrossRefPubMedGoogle Scholar
  15. 15.
    Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, Lacey JV Jr (2012) Age-specific incidence of breast cancer subtypes: understanding the black–white crossover. J Natl Cancer Inst 104(14):1094–1101. doi: 10.1093/jnci/djs264 CrossRefPubMedGoogle Scholar
  16. 16.
    Nederend J, Duijm LE, Louwman MW, Groenewoud JH, Donkers-van Rossum AB, Voogd AC (2012) Impact of transition from analog screening mammography to digital screening mammography on screening outcome in The Netherlands: a population-based study. Ann Oncol 23(12):3098–3103. doi: 10.1093/annonc/mds146 CrossRefPubMedGoogle Scholar
  17. 17.
    van Ravesteyn NT, Miglioretti DL, Stout NK, Lee SJ, Schechter CB, Buist DS, Huang H, Heijnsdijk EA, Trentham-Dietz A, Alagoz O, Near AM, Kerlikowske K, Nelson HD, Mandelblatt JS, de Koning HJ (2012) Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk. Ann Intern Med 156(9):609–617. doi: 10.1059/0003-4819-156-9-201205010-00002 PubMedGoogle Scholar
  18. 18.
    Kirsh VA, Chiarelli AM, Edwards SA, O’Malley FP, Shumak RS, Yaffe MJ, Boyd NF (2011) Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program. J Natl Cancer Inst 103(12):942–950. doi: 10.1093/jnci/djr138 CrossRefPubMedGoogle Scholar
  19. 19.
    Bluekens AM, Holland R, Karssemeijer N, Broeders MJ, den Heeten GJ (2012) Comparison of digital screening mammography and screen-film mammography in the early detection of clinically relevant cancers: a multicenter study. Radiology 265(3):707–714. doi: 10.1148/radiol.12111461 CrossRefPubMedGoogle Scholar
  20. 20.
    Pisano ED, Gatsonis C, Hendrick E, Yaffe M, Baum JK, Acharyya S, Conant EF, Fajardo LL, Bassett L, D’Orsi C, Jong R, Rebner M (2005) Diagnostic performance of digital versus film mammography for breast-cancer screening. N Engl J Med 353(17):1773–1783. doi: 10.1056/NEJMoa052911 CrossRefPubMedGoogle Scholar
  21. 21.
    Ryerson AB, Miller JW, Eheman CR, Leadbetter S, White MC (2008) Recent trends in US mammography use from 2000 to 2006: a population-based analysis. Prev Med 47(5):477–482. doi: 10.1016/j.ypmed.2008.06.010 CrossRefPubMedGoogle Scholar
  22. 22.
    Miller JW, King JB, Joseph DA, Richardson LC (2012) Breast cancer screening among adult women—behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep 61(Suppl):46–50PubMedGoogle Scholar
  23. 23.
    Breen N, Gentleman JF, Schiller JS (2011) Update on mammography trends: comparisons of rates in 2000, 2005, and 2008. Cancer 117(10):2209–2218. doi: 10.1002/cncr.25679 CrossRefPubMedGoogle Scholar
  24. 24.
    U.S. Preventive Services Task Force (2002) Screening for breast cancer: recommendations and rationale. Ann Intern Med 137(5 Part 1):344–346Google Scholar
  25. 25.
    U.S. Preventive Services Task Force (2009) Screening for breast cancer: US preventive services task force recommendation statement. Ann Intern Med 151(10):716–726. doi: 10.1059/0003-4819-151-10-200911170-00008 W-236Google Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Health StudiesUniversity of ChicagoChicagoUSA

Personalised recommendations